These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18203522)

  • 21. [Effects of Gosha-Jinki-Gan on the function of the urinary bladder in anesthetized dogs].
    Suzuki T; Kurokawa K; Suzuki K; Higashi H; Ohma C; Imai K; Yamanaka H
    Hinyokika Kiyo; 1996 Dec; 42(12):951-5. PubMed ID: 9013230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
    Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
    Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z
    J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
    Takahashi S; Tajima A; Matsushima H; Kawamura T; Tominaga T; Kitamura T
    Int J Urol; 2006 Jan; 13(1):15-20. PubMed ID: 16448426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Darifenacin treatment of patients >or= 65 years with overactive bladder: results of a randomized, controlled, 12-week trial.
    Chapple C; DuBeau C; Ebinger U; Rekeda L; Viegas A
    Curr Med Res Opin; 2007 Oct; 23(10):2347-58. PubMed ID: 17706004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of herbal medicine Weng-li-tong with Tolterodine may be better than Tolterodine alone in the treatment of overactive bladder in women: a randomized placebo-controlled prospective trial.
    Xiao DD; Lv JW; Xie X; Jin XW; Lu MJ; Shao Y
    BMC Urol; 2016 Aug; 16(1):49. PubMed ID: 27503124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
    Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
    Cardozo L; Hessdörfer E; Milani R; Arañó P; Dewilde L; Slack M; Drogendijk T; Wright M; Bolodeoku J;
    BJU Int; 2008 Nov; 102(9):1120-7. PubMed ID: 18990175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study.
    Noguchi M; Kakuma T; Tomiyasu K; Kurita Y; Kukihara H; Konishi F; Kumamoto S; Shimizu K; Kondo R; Matsuoka K
    Asian J Androl; 2008 Jul; 10(4):651-8. PubMed ID: 18097503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ["Pathophysiology and treatment of the overactive bladder"].
    Yokoyama O
    Hinyokika Kiyo; 2005 Sep; 51(9):599-601. PubMed ID: 16229372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia.
    Yagi H; Nishio K; Sato R; Arai G; Soh S; Okada H
    J Tradit Complement Med; 2016 Jan; 6(1):126-9. PubMed ID: 26870690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Gosha-jinki-gan, a blended herbal medicine, on bladder activity in rats.
    Nishijima S; Sugaya K; Miyazato M; Ogawa Y
    J Urol; 2007 Feb; 177(2):762-5. PubMed ID: 17222677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder.
    Homma Y; Yamaguchi T; Yamaguchi O
    Int J Urol; 2008 Sep; 15(9):809-15. PubMed ID: 18637156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Sep; 90(9):1821-7. PubMed ID: 17957925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score.
    Ohgaki K; Horiuchi K; Kondo Y
    Urology; 2012 Jun; 79(6):1372-8. PubMed ID: 22656415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of imidafenacin in female patients with urge and mixed urinary incontinence].
    Shimada M; Inoue K; Okumura T; Aoki S; Ogawa Y; Matsubara E; Maeda T; Ogawa Y; Sasaki H
    Hinyokika Kiyo; 2011 Jan; 57(1):1-6. PubMed ID: 21304252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M; Matsukawa Y; Kato K; Kondo A; Yamada S; Hattori R; Gotoh M
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.